The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
Felice Crocetto(University of Naples Federico II), Marina Di Domenico(University of Campania "Luigi Vanvitelli"), Giuliana Settembre(University of Campania "Luigi Vanvitelli"), Mariarosaria Boccellino(University of Campania "Luigi Vanvitelli"), Italo Francesco Angelillo(University of Campania "Luigi Vanvitelli"), Giovanni Galasso(University of Campania "Luigi Vanvitelli"), Lucio Quagliuolo(University of Naples Federico II), Ciro Imbimbo(University of Naples Federico II), Silvia Boffo(Temple College), Erika Di Zazzo(University of Molise), Biagio Barone(Ospedale San Paolo), Antonella Sciarra(University of Campania "Luigi Vanvitelli")
Cited by 64
Related Papers
ROS in cancer therapy: the bright side of the moon
|Experimental & Molecular Medicine|2020|2.2k
The Androgen Receptor in Breast Cancer
|Frontiers in Endocrinology|2018|206
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Adiponectin as Link Factor between Adipose Tissue and Cancer
|International Journal of Molecular Sciences|2019|138